cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Verrica Pharmaceuticals Inc
3 own
5 watching
Current Price
$3.79
$0.04
(1.07%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
238.56M
52-Week High
52-Week High
8.69500
52-Week Low
52-Week Low
2.02000
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization238.56M
icon52-Week High8.69500
icon52-Week Low2.02000
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio--
What does the Verrica Pharmaceuticals Inc do?
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company s lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Read More
How much money does Verrica Pharmaceuticals Inc make?
News & Events about Verrica Pharmaceuticals Inc.
Globe Newswire
5 months ago
WEST CHESTER, Pa., April 12, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica or, the Company) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the first patient has been dosed in Part 2 of...
Zolmax
5 months ago
Entrada Therapeutics (NASDAQ:TRDA Get Rating) and Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, ...
Ticker Report
7 months ago
Royal Bank of Canada upgraded shares of Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) from a sector perform rating to an outperform rating in a report released on Monday, Marketbeat reports. The brokerage currently has $11.00 price objective on the stock. Verrica Pharmaceuticals Price ...
Globe Newswire
8 months ago
Registration Stability Batch for VP-102 Completed and Placed on Stability Process Validation Batches Successfully Manufactured Verrica Reaffirms its Expected Q1 2023 NDA Resubmission for VP-102 WEST CHESTER, Pa., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA...
Ticker Report
10 months ago
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, ...
Frequently Asked Questions
Frequently Asked Questions
What is Verrica Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Verrica Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Verrica Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Verrica Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Verrica Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Verrica Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Verrica Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Verrica Pharmaceuticals Inc?
plus_minus_icon
What percentage is Verrica Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Verrica Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.79
$0.04
(1.07%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SUTRO BIOPHARMA INC
SUTRO BIOPHARMA INC
$3.29
$-0.09 (-2.59 %)
INOZYME PHARMA INC
INOZYME PHARMA INC
$4.60
$-0.01 (-0.22 %)
Gracell Biotechnologies Inc
Gracell Biotechnologies Inc
$3.04
$0.13 (4.47 %)
ADC Therapeutics SA
ADC Therapeutics SA
$0.72
$-0.01 (-1.26 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
SUTRO BIOPHARMA INC
SUTRO BIOPHARMA INC
$3.29
$-0.09 (-2.59 %)
INOZYME PHARMA INC
INOZYME PHARMA INC
$4.60
$-0.01 (-0.22 %)
Gracell Biotechnologies Inc
Gracell Biotechnologies Inc
$3.04
$0.13 (4.47 %)
ADC Therapeutics SA
ADC Therapeutics SA
$0.72
$-0.01 (-1.26 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00